Hanmi Science has decided to retire 448,286 treasury shares (own shares) it holds. The scheduled retirement amount is approximately 9.3636 billion won, and the method utilizes treasury shares already acquired and held, rather than newly purchasing shares. This is equivalent to about 0.66% of the total 68,391,550 issued shares.

According to the share retirement decision disclosure filed by Hanmi Science on the 27th, the subject of this retirement is 448,286 common shares, with a scheduled retirement amount of 9,363,585,341 won. The amount was calculated based on the book value of the shares to be retired, and the par value per share is 500 won. The scheduled retirement date is November 2, although the schedule may change depending on consultations with relevant institutions.

Board Resolution Method, Not a Capital Reduction

This retirement is distinct from a capital reduction, which reduces a company's capital. Hanmi Science explained that it will retire its treasury shares through a board resolution without a capital reduction procedure, pursuant to the proviso of Article 343, Paragraph 1 of the revised Commercial Act. Accordingly, while the total number of issued shares will decrease due to the retirement of treasury shares, no capital reduction procedure will accompany it. The board resolution date was October 27, attended by three independent outside directors. This retirement is not subject to reporting to the Fair Trade Commission.

No Direct Change in Existing Shareholders' Holdings

The retirement of treasury shares is a matter that affects the number of tradable shares and the total number of issued shares. However, since this retirement targets treasury shares already held by the company, the number of shares held by existing shareholders will not be directly changed.

This decision draws attention in that the company is retiring treasury shares equivalent to about 0.66% of its total issued shares. Whether the retirement is actually completed and the final schedule will need to be confirmed through relevant procedures going forward.

[This article is intended to provide information for investment reference and does not recommend the purchase or sale of any specific stock. Content may vary depending on market conditions. Investment decisions and the responsibility for them rest with the investor. AI provided partial assistance.]